EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study

Roberto Rordorf iD, Leonardo Pignalosa, Matteo Casula iD, Enrico Perna, Matteo Baroni, Andrea Garascia, Stefania Guida, Fabrizio Gazzoli, Daniela Pini, Francesco Cannata iD, Marta Pellegrino, Claudia Vittori und 6 weitere

Artificial Organs · 2024

DOI: 10.1111/aor.14708 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Artificial Organs, 2024. Verfasst von Roberto Rordorf und 17 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia and Electrophysiology Unit, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Heart Failure, Heart-Assist Devices, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Left ventricular assist device (L‐VAD) implantation is increasingly used in patients with heart failure (HF) and most patients also have an implantable cardioverter defibrillator (ICD). Limited data are available on the incidence of ICD therapies and complications in this special setting. The aim of this study was to analyze the real‐world incidence and predictors of ICD therapies, complications and interactions between ICD and L‐VAD.

Methods

We conducted a multicenter retrospective observational study in patients with advanced HF implanted with ICD and a continuous‐flow L‐VAD, followed‐up in five advanced HF centers in Northern Italy.

Results

A total of 234 patients (89.7% male, median age 59, 48.3% with ischemic etiology) were enrolled. After a median follow‐up of 21 months, 66 patients (28.2%) experienced an appropriate ICD therapy, 22 patients (9.4%) an inappropriate ICD therapy, and 17 patients (7.3%) suffered from an interaction between ICD and L‐VAD. The composite outcome of all ICD‐related complications was reported in 41 patients (17.5%), and 121 (51.7%) experienced an L‐VAD‐related complication. At multivariable analysis, an active ventricular tachycardia (VT) zone and a prior ICD generator replacement were independent predictors of ICD therapies and of total ICD‐related complications, respectively.

Conclusions

Real‐world patients with both L‐VAD and ICD experience a high rate of ICD therapies and complications. Our findings suggest the importance of tailoring device programming in order to minimize the incidence of unnecessary ICD therapies, thus sparing the need for ICD generator replacement, a procedure associated to a high risk of complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableHeart FailureHeart-Assist DevicesTachycardia, VentricularFemaleHumansMaleArrhythmias, CardiacRetrospective StudiesTreatment OutcomeMiddle Aged

Stichwörter der Autor:innen

ICD complicationsICD programmingend‐stage heart failureimplantable cardioverter‐defibrillator (ICD)left ventricular assist device

Autor:innen und Institutionen

  • Arrhythmia and Electrophysiology Unit, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy.
  • De Gasperis CardioCenter, Niguarda Hospital, Milan, Italy.
  • Division of Cardiology, IRCCS Policlinico S. Matteo, Pavia, Italy.
  • Division Cardiac Surgery, IRCCS Policlinico S. Matteo, Pavia, Italy.
  • Department of Perioperative Cardiology and Cardiovascular imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.

ORCID-Profile: Roberto Rordorf, Matteo Casula, Francesco Cannata

Zitieren

APA

Rordorf, R., Pignalosa, L., Casula, M., Perna, E., Baroni, M., Garascia, A., Guida, S., Gazzoli, F., Pini, D., Cannata, F., Pellegrino, M., Vittori, C., De Filippo, P., Malanchini, G., Vergara, P., Della Bella, P., Gulletta, S., & all the Investigators of the study (2024). Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study. Artificial Organs. https://doi.org/10.1111/aor.14708

Vancouver

Rordorf R, Pignalosa L, Casula M, Perna E, Baroni M, Garascia A, et al. Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study. Artificial Organs. 2024. doi:10.1111/aor.14708

BibTeX
@article{Rordorf2024,
  author = {Rordorf, Roberto and Pignalosa, Leonardo and Casula, Matteo and Perna, Enrico and Baroni, Matteo and Garascia, Andrea and Guida, Stefania and Gazzoli, Fabrizio and Pini, Daniela and Cannata, Francesco and Pellegrino, Marta and Vittori, Claudia and De Filippo, Paolo and Malanchini, Giovanni and Vergara, Pasquale and Della Bella, Paolo and Gulletta, Simone and all the Investigators of the study, all the Investigators of the study},
  title = {Real‐world data of patients affected by advanced heart failure treated with implantable cardioverter defibrillator and left ventricular assist device: Results of a multicenter observational study},
  journal = {Artificial Organs},
  year = {2024},
  doi = {10.1111/aor.14708}
}
Kostenlos starten →